Article

Silodosin — a safer alpha-blocker targeting benign prostatic hyperplasia

Published in: South African Family Practice
Volume 57 , issue 5 , 2015 , pages: 291–292

DOI: 10.1080/20786190.2014.978099

Author(s): Karen Koch Private practice GP and freelance medical writer, South Africa

Keywords: alpha-1A receptor inhibitor , Benign prostatic hypertrophy , BPH , lower urinary tract symptoms

Abstract

Silodosin is a specific alpha-1A receptor inhibitor newly available in South Africa. It offers a real solution to symptoms of BPH especially in those patients with moderate prostate enlargement experiencing nocturia, frequency and incomplete voiding.

« Diet and childhood asthma: review

Diplopia »